Compare VSME & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | VSME | PTHL |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | Hong Kong | China |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.8M |
| IPO Year | 2023 | 2024 |
| Metric | VSME | PTHL |
|---|---|---|
| Price | $0.11 | $0.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 76.8K |
| Earning Date | 12-21-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,483,152.00 | $448,196.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.10 | $0.47 |
| 52 Week High | $3.21 | $32.00 |
| Indicator | VSME | PTHL |
|---|---|---|
| Relative Strength Index (RSI) | 19.84 | 41.04 |
| Support Level | $0.14 | $0.59 |
| Resistance Level | $0.18 | $0.63 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 1.98 | 36.70 |
VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.